P59 Comparative Efficacy and Safety of Ozanimod and Ponesimod for Relapsing Multiple Sclerosis: A Matching-Adjusted Indirect Comparison
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.076
https://www.valueinhealthjournal.com/article/S1098-3015(22)00277-7/fulltext
Title :
P59 Comparative Efficacy and Safety of Ozanimod and Ponesimod for Relapsing Multiple Sclerosis: A Matching-Adjusted Indirect Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00277-7&doi=10.1016/j.jval.2022.04.076
First page :
Section Title :
Open access? :
No
Section Order :
10064